Clinical Trials for Neuroendocrine Tumors

Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

NCT ID: NCT06540937

This clinical trial is studying a medication called leflunomide to see how well it works in treating advanced neuroendocrine tumors associated with MEN-1 syndrome, especially for patients who have ...

68Ga-DOTA-TATE PET/CT Imaging in NETs

NCT ID: NCT04847505

This clinical trial is studying a new imaging tool called 68Ga-DOTA-TATE PET/CT to see if it is safe and effective for diagnosing neuroendocrine tumors (NETs). Previous research has already shown t...

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

NCT ID: NCT05997056

This clinical trial is studying a medication called nab-sirolimus to see how well it works for patients with certain types of neuroendocrine tumors (NETs) that are well-differentiated, meaning they...

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

NCT ID: NCT06485739

This clinical trial is studying a treatment for patients with specific types of neuroendocrine tumors, particularly gastrointestinal pancreatic neuroendocrine carcinoma. The treatment involves usin...

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

NCT ID: NCT06395402

This clinical trial is studying whether a personalized approach to prescribing Lutetium-177 DOTATATE (also known as Lutathera) can lead to better treatment outcomes for adults with certain types of...

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

NCT ID: NCT03935893

This clinical trial is studying a new treatment approach for patients with advanced solid cancers such as gastric, colorectal, pancreatic cancer, and others. The treatment involves using the patien...

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

NCT ID: NCT06472388

This clinical trial is studying the effects of a medication called everolimus, comparing two different doses: 5 mg and 10 mg taken daily. Everolimus is used to treat patients with advanced neuroend...

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

NCT ID: NCT05396118

Observational Study on GEP-and Pulm-NET Treated at FPG

NCT ID: NCT06402695

This clinical trial is studying patients with neuroendocrine tumors (NETs) that occur in the gastroenteropancreatic tract or the lungs. The researchers want to understand the characteristics of the...

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT ID: NCT05500391

This clinical trial is looking to compare two different ways of monitoring patients who have recently been diagnosed with certain rare tumors. The goal is to see if patients are more likely to foll...

Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications

NCT ID: NCT06321692

This clinical trial is looking at patients who have neuroendocrine tumors (NET), which are a type of cancer that can affect various organs. Specifically, the study aims to find out more about how t...

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT ID: NCT03452774

The SYNERGY-AI trial is exploring how artificial intelligence (AI) can help match cancer patients with the most suitable clinical trials. This study focuses on patients with various types of advanc...

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

NCT ID: NCT05475210

This clinical trial is investigating a treatment called 177Lu-DOTA-EB-TATE for adults who have advanced neuroendocrine tumors (NETs) that cannot be surgically removed. The goal of the study is to s...

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment

NCT ID: NCT05334290

This clinical trial is studying the financial impact of treatment on patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NEN) in Italy. Specifically, it aims to understand how...

Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.

NCT ID: NCT06159920

This clinical trial is looking at how well a type of imaging test called PET (which stands for positron emission tomography) can help diagnose and monitor neuroendocrine tumors (NETs). These tumors...

A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors

NCT ID: NCT06300216

This clinical trial is looking at the use of a treatment called octreotide microspheres for patients with advanced neuroendocrine tumors, which are a type of cancer that can occur in various organs...

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

NCT ID: NCT04889742

This clinical trial is studying a new treatment approach for patients with recurrent cancer who have already received radiation therapy in the past. The researchers want to see if using heat (calle...

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

NCT ID: NCT05709171

Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors

NCT ID: NCT04897542

This clinical trial is studying a new imaging method using a substance called Gallium-68 NODAGA-JR11 to see how well it can detect neuroendocrine tumors, which are a type of cancer. The researchers...

Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

NCT ID: NCT06015802

This clinical trial is studying how certain markers in blood and tissue, as well as imaging features, can help predict the behavior and future risks of pituitary neuroendocrine tumors, specifically...